The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

about

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease

P2860

Q26748481-289FE9E2-65FC-4D7A-9915-C0C92E72C0EC

P2860

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

Item

http://www.wikidata.org/entity/Q26797273

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@ast

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@en

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@nl

type

Item

label

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@ast

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@en

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@nl

prefLabel

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@ast

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@en

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@nl

P1476

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

@en

P2093

George P Patrinos

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolomics: moving towards personalized medicine

Technique for intrapartum administration of surfactant without requirement for an endotracheal tube.

A metabolomic study of preterm human and formula milk by high resolution NMR and GC/MS analysis: preliminary results.

The composition of human milk.

Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

Pharmacogenomics and individualized medicine: translating science into practice.

Metabolomics: a global biochemical approach to drug response and disease.

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome

Paternal age and offspring congenital heart defects: a national cohort study.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPED.2015.00068

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Theodora Katsila

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280546496

http://www.w3.org/2001/XMLSchema#string

P698

26284229

http://www.w3.org/2001/XMLSchema#string

P932

4518156

http://www.w3.org/2001/XMLSchema#string

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

about

P2860

P2860

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932